SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare - Quaterly Results

10 Nov 2023 Evaluate
The revenue for the September 2023 quarter is pegged at Rs. 746.14 millions, about 8.56% up against Rs. 687.31 millions recorded during the year-ago period.The Total Profit for the quarter ended September 2023 of Rs. 66.04 millions grew from Rs.-196.24 millions Operating profit Margin for the quarter ended September 2023 improved to 300.53% as compared to -63.88% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 746.14 687.31 8.56 1583.55 1295.65 22.22 2477.02 3569.52 -30.61
Other Income 227.61 180.87 25.84 435.43 307.15 41.76 686.44 408.62 67.99
PBIDT 300.53 -63.88 -570.46 661.75 107.42 516.04 246.44 625.49 -60.60
Interest 51.78 49.17 5.31 119.38 75.76 57.58 208.25 90.54 130.01
PBDT 246.63 -118.90 -307.43 476.88 25.81 1747.66 -117.27 623.04 -118.82
Depreciation 126.67 118.91 6.53 249.30 223.12 11.73 465.48 348.18 33.69
PBT 119.96 -237.81 -150.44 227.58 -197.31 -215.34 -582.75 274.86 -312.02
TAX 53.92 -41.57 -229.71 82.53 -39.61 -308.36 -87.93 73.27 -220.01
Deferred Tax -5.36 18.39 -129.15 4.45 13.25 -66.42 -4.27 25.25 -116.91
PAT 66.04 -196.24 -133.65 145.05 -157.70 -191.98 -494.82 201.59 -345.46
Equity 86.80 86.80 0.00 86.80 86.80 0.00 86.80 86.80 0.00
PBIDTM(%) 40.28 -9.29 -533.37 41.79 8.29 404.04 9.95 17.52 -43.22

Shilpa Medicare Share Price

411.55 0.30 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×